161 related articles for article (PubMed ID: 11333452)
1. Tumour necrosis factor blockade in rheumatoid arthritis.
Breedveld FC
Clin Med (Lond); 2001; 1(2):107-9. PubMed ID: 11333452
[No Abstract] [Full Text] [Related]
2. Anti-TNF agents for rheumatoid arthritis.
Seymour HE; Worsley A; Smith JM; Thomas SH
Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
[No Abstract] [Full Text] [Related]
4. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
Amano K
Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
[No Abstract] [Full Text] [Related]
6. Which TNF inhibitor for rheumatoid arthritis?
Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
[No Abstract] [Full Text] [Related]
7. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
8. [Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
Imagama T; Taguchi T
Nihon Rinsho; 2013 Jul; 71(7):1209-13. PubMed ID: 23961668
[TBL] [Abstract][Full Text] [Related]
9. Infliximab: a new treatment for rheumatoid arthritis.
Emery P
Hosp Med; 2001 Mar; 62(3):150-2. PubMed ID: 11291464
[TBL] [Abstract][Full Text] [Related]
10. [Infliximab for therapy of rheumatoid arthritis].
Amano K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():517-20. PubMed ID: 15799410
[No Abstract] [Full Text] [Related]
11. [TNF targetting therapy for rheumatoid arthritis].
Takeuchi T
Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1787-94. PubMed ID: 17037316
[No Abstract] [Full Text] [Related]
12. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
Guillevin L; Mouthon L
J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
[No Abstract] [Full Text] [Related]
13. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
[No Abstract] [Full Text] [Related]
14. Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists.
Curtis JR; Xi J; Patkar N; Xie A; Saag KG; Martin C
Arthritis Rheum; 2007 Dec; 56(12):4226-7. PubMed ID: 18050253
[No Abstract] [Full Text] [Related]
15. Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.
Emery P; Buch M
BMJ; 2002 Feb; 324(7333):312-3. PubMed ID: 11834544
[No Abstract] [Full Text] [Related]
16. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
[No Abstract] [Full Text] [Related]
17. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
Asahina A; Ishii N; Tohma S
J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
[No Abstract] [Full Text] [Related]
18. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
Geraghty EM; Ristow B; Gordon SM; Aronowitz P
Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
[TBL] [Abstract][Full Text] [Related]
19. Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
Sidiropoulos PI; Boumpas DT
Ann Rheum Dis; 2006 Jun; 65(6):701-3. PubMed ID: 16699049
[TBL] [Abstract][Full Text] [Related]
20. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
